Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
COYOTE
company
About
Coyote Bioscience is the developer of point-of-care molecular diagnostics, pathogen detection, and life science tools.
- 1 - 10
Details
- Last Funding Type
- Series E
- Last Funding Money Raised
- ¥50M
- Industries
- Biotechnology,Health Diagnostics,Medical
- Founded date
- Dec 4, 2009
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
¥130M
COYOTE has raised a total of
¥130M
in funding over 2 rounds. Their latest funding was raised on
Mar 28, 2019 from a Series E round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 28, 2019 | Series E | ¥50M | 3 | — | — | Detail |
| Jul 31, 2018 | Series D | ¥50M | 1 |
|
— | Detail |
| Sep 22, 2017 | Series C | ¥30M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
6
COYOTE is funded by 6 investors.
Shanghai Real Estate Asset Management
and Jilin Yanglao Jijin
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series D |
|
|
— | Series E |
|
|
— | Series E |
|
|
— | Series E |
|
|
— | Series C |
New Founder
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
